why choose us

First received: April 17, 2023

Clinical Trial: Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders

Study Status: Completed

Recruit Status: RECRUITING

Condition: Schizophrenia

Study Type: INTERVENTIONAL


Official Title: Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders

Brief Summary: This pilot open-label study examines the effects of a combination of dasatinib plus quercetin - two drugs that have known senolytics properties - on physiological aging in older individuals with depression or schizophrenia.

Read more